Net Loss per Share (Tables)

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Summary Of Anti-Dilutive Shares

The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to Ginkgo Bioworks Holdings, Inc. common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):

	As of June 30,
	2023		2022
Warrants to purchase Class A common stock		51,825		51,825
Outstanding stock options		11,796		21,453
Unvested RSUs		184,236		214,272
Unvested RSAs		—		93
Earnout shares (1)		152,318		160,521
		400,175		448,164

(1) Represents earnout shares for which the service-based vesting conditions and/or market conditions have not been met.